Correlation Between Rezolute and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Rezolute and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Rezolute and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Anebulo Pharmaceuticals.
Diversification Opportunities for Rezolute and Anebulo Pharmaceuticals
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Rezolute and Anebulo is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Rezolute i.e., Rezolute and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Rezolute and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Rezolute is expected to generate 0.72 times more return on investment than Anebulo Pharmaceuticals. However, Rezolute is 1.4 times less risky than Anebulo Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest 485.00 in Rezolute on August 31, 2024 and sell it today you would earn a total of 14.00 from holding Rezolute or generate 2.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Rezolute vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Rezolute |
Anebulo Pharmaceuticals |
Rezolute and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rezolute and Anebulo Pharmaceuticals
The main advantage of trading using opposite Rezolute and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.The idea behind Rezolute and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Anebulo Pharmaceuticals vs. Cue Biopharma | Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. Inhibrx | Anebulo Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |